IRIS
BARICICH, Alessio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.711
EU - Europa 4.602
AS - Asia 2.742
SA - Sud America 475
Continente sconosciuto - Info sul continente non disponibili 220
AF - Africa 139
OC - Oceania 15
Totale 12.904
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.509
RU - Federazione Russa 1.102
IE - Irlanda 827
SG - Singapore 822
IT - Italia 721
CN - Cina 584
FR - Francia 454
HK - Hong Kong 412
DE - Germania 400
SE - Svezia 380
VN - Vietnam 352
BR - Brasile 343
UA - Ucraina 241
GB - Regno Unito 140
IN - India 129
CA - Canada 118
FI - Finlandia 115
KR - Corea 65
BD - Bangladesh 57
AR - Argentina 53
ID - Indonesia 49
JP - Giappone 49
IR - Iran 47
BJ - Benin 41
NL - Olanda 38
ES - Italia 33
ZA - Sudafrica 32
MX - Messico 30
TR - Turchia 30
PL - Polonia 26
BE - Belgio 24
CZ - Repubblica Ceca 24
IQ - Iraq 24
EG - Egitto 23
EC - Ecuador 22
PK - Pakistan 19
AT - Austria 17
MY - Malesia 16
AU - Australia 15
PE - Perù 13
PH - Filippine 12
CL - Cile 11
KE - Kenya 11
PY - Paraguay 11
LT - Lituania 10
TW - Taiwan 10
UZ - Uzbekistan 9
VE - Venezuela 9
JM - Giamaica 8
JO - Giordania 8
SA - Arabia Saudita 8
TH - Thailandia 8
DZ - Algeria 7
GT - Guatemala 7
NG - Nigeria 7
NI - Nicaragua 7
RS - Serbia 7
TT - Trinidad e Tobago 7
CH - Svizzera 6
EE - Estonia 5
TN - Tunisia 5
BG - Bulgaria 4
BS - Bahamas 4
CO - Colombia 4
HN - Honduras 4
MA - Marocco 4
MD - Moldavia 4
MO - Macao, regione amministrativa speciale della Cina 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CR - Costa Rica 3
GR - Grecia 3
KZ - Kazakistan 3
LV - Lettonia 3
MK - Macedonia 3
OM - Oman 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
SV - El Salvador 3
UY - Uruguay 3
BO - Bolivia 2
BY - Bielorussia 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
EU - Europa 2
GY - Guiana 2
IL - Israele 2
KH - Cambogia 2
LB - Libano 2
LI - Liechtenstein 2
PR - Porto Rico 2
SC - Seychelles 2
AG - Antigua e Barbuda 1
AL - Albania 1
BM - Bermuda 1
BN - Brunei Darussalam 1
CG - Congo 1
CY - Cipro 1
Totale 12.670
Salva come PNG Salva come JPEG
Città #
Dublin 819
San Jose 486
Hong Kong 394
Jacksonville 393
Singapore 334
Council Bluffs 320
Ashburn 284
Beijing 178
Dearborn 168
Chandler 161
Los Angeles 134
Columbus 117
Wilmington 117
Lauterbourg 113
Moscow 113
Ho Chi Minh City 105
Princeton 100
Lawrence 98
Ann Arbor 87
Phoenix 79
New York 75
Buffalo 74
Hanoi 73
Piemonte 70
San Mateo 67
Santa Clara 56
Seoul 52
Dallas 49
Novara 47
Milan 46
São Paulo 45
Munich 44
Rome 44
Turin 43
Helsinki 42
Orem 42
Cotonou 41
Montreal 38
Chennai 34
Boardman 32
Andover 31
Dong Ket 30
Frankfurt am Main 30
Bremen 27
Nuremberg 27
Vercelli 26
Jakarta 25
Johannesburg 25
Brussels 24
Chicago 23
Poplar 23
Redondo Beach 23
Falkenstein 22
Toronto 22
Brno 21
London 21
Tokyo 21
Warsaw 21
Stockholm 20
Amsterdam 19
Atlanta 17
Guangzhou 17
Haiphong 17
Houston 17
Brooklyn 16
Denver 15
Nanjing 15
Tianjin 15
Manchester 14
Vienna 14
Ankara 13
Boston 13
Zanjan 13
Da Nang 12
Hangzhou 12
Mumbai 12
North Bergen 12
Schaumburg 12
Woodbridge 12
Fairfield 11
Mexico City 11
Seattle 11
Turku 11
Kunming 10
Monza 10
Nairobi 10
San Francisco 10
Shanghai 10
Al Maḩallah al Kubrá 9
Charlotte 9
Hefei 9
Naples 9
Ottawa 9
Alessandria 8
Amman 8
Baghdad 8
Bari 8
Belo Horizonte 8
Brasília 8
Cairo 8
Totale 6.558
Salva come PNG Salva come JPEG
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 411
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 275
Clinical and instrumental evaluation of Botulinum Toxin type A safety profile in post stroke spasticity rehabilitation treatment 257
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 214
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 205
A Rare Cause of Back Pain During Pregnancy and Lactation: Management and Treatment 173
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 173
Anxiety, Stress and Depression in COVID-19 Survivors From an Italian Cohort of Hospitalized Patients: Results From a 1-Year Follow-Up 167
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 167
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 166
Mid-term Psychiatric Outcomes of Patients Recovered From COVID-19 From an Italian Cohort of Hospitalized Patients 166
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques. 164
Buccal hemineglect: is it useful to evaluate the differences between the two halves of the oral cavity for the multidisciplinary rehabilitative management of right brain stroke survivors? A cross-sectional study 162
Sarcopenic dysphagia: a narrative review 162
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 161
Can scoliosis lead to spinal cord ischaemia? Early diagnosis and rehabilitation: A paradigmatic case report and literature review 146
The Lack of Systemic and Subclinical Side Effects of Botulinum Neurotoxin Type-A in Patients Affected by Post-Stroke Spasticity: A Longitudinal Cohort Study 144
Post-COVID-19 sequelae are associated with sustained SARS-CoV-2-specific CD4+ immune responses 142
A new mutation in the CAVIN1/PTRF gene in two siblings with congenital generalized lipodystrophy type 4: case reports and review of the literature 142
RIEDUCAZIONE DEL CAMMINO NEL MORBO DI PARKINSON: TRATTAMENTO ROBOTIZZATO VERSUS TRAINING SU TREADMILL. STUDIO RANDOMIZZATO CONTROLLATO 132
Adjuvant treatments associated with botulinum toxin injection for managing spasticity: An overview of the literature 132
Spinal Cord Injury as a Model of Bone-Muscle Interactions: Therapeutic Implications From in vitro and in vivo Studies 127
Effects of Denosumab on Bone Turnover Markers compared to Zoledronic Acid in severe osteoporotic women: a randomized head to head study 126
Heart Rate Variability modifications induced by high doses of incobotulinumtoxinA and onabotulinumtoxinA in hemiplegic chronic stroke patients: A single blind randomized controlled, crossover pilot study 126
Development of a patient-centered questionnaire for post-stroke spasticity assessment: a reliability study 120
Abobotulinumtoxina and rehabilitation vs rehabilitation alone in post-stroke spasticity: A cost-utility analysis 119
Long-lasting consequences of Coronavirus disease 19 pneumonia: a systematic review 119
Balance Rehabilitation through Robot-Assisted Gait Training in Post-Stroke Patients: A Systematic Review and Meta-Analysis 118
ONCE YEARLY ZOLEDRONIC ACID AFTER 18 MONTHS OF PARATHYROID HORMONE (1-84) FOR SEVERE OSTEOPOROSIS 118
Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patients 117
Accurate gait analysis in post-stroke patients using a single inertial measurement unit 116
Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke 115
MULTIMODAL ANALGESIA AND REHABILITATION PROTOCOL IN TOTAL KNEE REPLACEMENT: A PILOT STUDY 114
Peripheral facial nerve palsy: how effective is rehabilitation? 113
Administration of type a botulinum toxin after total hip replacement 113
Chronic stroke: an oxymoron or a challenge for rehabilitation? 109
Clinical characteristics that impact onabotulinumtoxinA treatment adherence in patients with spasticity from ASPIRE 109
Clinical efficacy of botulinum toxin type A in patients with traumatic brain injury, spinal cord injury, or multiple sclerosis: An observational longitudinal study 107
Recovery from vegetative state of patients with a severe brain injury: a 4-year real-practice prospective cohort study 107
Long-term effects of intra-articular oxygen-ozone therapy versus hyaluronic acid in older people affected by knee osteoarthritis: A randomized single-blind extension study 106
Efficacy of a Hip Flexion Assist Orthosis in Adults With Hemiparesis After Stroke. 105
Evaluation of the safety profile of intra-articular treatment with Oxygen-Ozone therapy in knee arthrosis: controlled randomized study 104
A single-blinded,randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot 103
Robotic gait training is not superior to conventional treadmill training in Parkinson's Disease: A single-blind randomized controlled trial 103
Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study 102
What is the impact of robotic rehabilitation on balance and gait outcomes in people with multiple sclerosis? A systematic review of randomized control trials 101
La valutazione dell’outcome nel percorso riabilitativo della protesi di ginocchio 100
ADHERENCE TO ONABOTULINUMTOXINA TREATMENT IN POST-STROKE PATIENTS WITH SPASTICITY FROM THE ASPIRE STUDY 100
Optimization of transdisciplinary management of elderly with femur proximal extremity fracture: A patient-tailored plan from orthopaedics to rehabilitation 100
The value of adding mirror therapy for upper limb motor recovery of subacute stroke patients: a randomized controlled trial. 97
Post-stroke spasticity: follow-up and functional implications of chronic long-term treatment with botulinum toxin 96
High-Intensity Exercise Training Impact on Cardiorespiratory Fitness, Gait Ability, and Balance in Stroke Survivors: A Systematic Review and Meta-Analysis 96
Botulinum Toxin for Pain Relief in Cancer Patients: A Systematic Review of Randomized Controlled Trials 96
Heart rate variability (hrv) modifications in adult hemiplegic patients after botulinum toxin type a (nt-201) injection. 96
Sonographic and clinical effects of botulinum toxin Type A combined with extracorporeal shock wave therapy on spastic muscles of children with cerebral palsy 96
Low back pain related to a sacral insufficiency fracture: Role of paravertebral oxygen-ozone therapy in a paradigmatic case of nociplastic pain 96
Effects of robot-assisted gait training on postural instability in parkinson's disease: A systematic review 96
Risk factors and outcome in falls 95
Adherence to onabotulinumtoxina treatment in multiple sclerosis patients with spasticity from the aspire study 94
Power Doppler Ultrasound Findings before and after Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Pilot Study on Pain Reduction and Neovascularization Effect 93
BoNT-A for Post-Stroke Spasticity: Guidance on Unmet Clinical Needs from a Delphi Panel Approach 93
Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from the ASPIRE Study 93
Differentiation among bio- and augmented- feedback in technologically assisted rehabilitation 92
Triceps surae muscle characteristics in spastic hemiparetic stroke survivors treated with botulinum toxin type a: Clinical implications from ultrasonographic evaluation 92
Once Yearly Zoledronic Acid After 18 months of Parathyroid Hormone (1-84) for Severe Osteoporosis 91
From paper to informatics: the Post Soft Care-App, an easy-to-use and fast tool to help therapists identify unmet needs in stroke patients 91
Rectus femoris characteristics in post stroke spasticity: Clinical implications from ultrasonographic evaluation 91
Efficacy and safety of a hip flexion assist orthosis in adult hemiplegic stroke patients 90
People with Spinal Cord Injury in Italy 90
Myostatin as a potential biomarker to monitor sarcopenia in hip fracture patients undergoing a multidisciplinary rehabilitation and nutritional treatment: a preliminary study 90
Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study 90
Robotic gait training is not superior to conventional treadmill training in parkinson disease: a single-blind randomized controlled trial. 88
Multidimensional Effectiveness of Botulinum Toxin in Neuropathic Pain: A Systematic Review of Randomized Clinical Trials 88
Tolerability, Safety and Efficacy of a Specific Rehabilitation Treatment Protocol for Axillary Web Syndrome: An Observational Retrospective Study 88
Confronto randomizzato, controllato in doppio cieco tra casting e taping nel trattamento riabilitativo dopo tossina botulinica A 87
Effects of Robot-Assisted Training for the Unaffected Arm in Patients with Hemiparetic Cerebral Palsy: A Proof-of-Concept Pilot Study 87
ADHERENCE TO ONABOTULINUMTOXINA TREATMENT IN PATIENTS WITH SPASTICITY FROM THE ASPIRE STUDY 87
Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke 86
ABOBOTULINUMTOXINA AND REHABILITATION VERSUS REHABILITATION ALONE IN POSTSTROKE SPASTICITY: AN ITALIAN COST-UTILITY ANALYSIS 85
Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke 84
Indicatori di qualità per la continuità delle cure in Medicina Riabilitativa 83
Is spasticity always the same? An observational study comparing the features of spastic equinus foot in patients with chronic stroke and multiple sclerosis 83
Ultrasonographic evaluation of botulinum toxin injection site for the medial approach to tibialis posterior muscle in chronic stroke patients with spastic equinovarus foot: An observational study 83
Falls, fractures and bone density in Parkinson’s disease–a cross-sectional study 82
Reasons and Determinants of BoNT-A Treatment Discontinuation in Patients Living with Spasticity: A 10-Year Retrospective Analysis 81
Development of new biomarkers in the prevention of lymphedema related to breast cancer: a multidisciplinary challenge 81
Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from ASPIRE 81
Once yearly Zoledronic Acid in Osteoporotic PD Patients compared to agematched osteoporotic post menopausal women 80
High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis 79
Post Soft Care: Italian implementation of a post-stroke checklist software for primary care and identification of unmet needs in community-dwelling patients 79
Does altering inclination alter effectiveness of treadmill training for gait impairment after stroke? A randomized controlled trial. 79
Management of stroke patients submitted to botulinum toxin type a therapy: A Delphi survey of an Italian expert panel of specialist injectors 78
Ultrasound-guided injection of botulinum toxin type a for piriformis muscle syndrome: A case report and review of the literature 78
Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment 77
Different PTH response to oral peptone load and oral calcium load in patients with normocalcemic primary hyperparathyroidism, primary hyperparathyroidism, and healthy subjects 76
Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity 75
Adjunctive treatment and BoNT-A for post-stroke spasticity: Are we really focusing on the patient-centered goals? 73
Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study 73
Management of spasticity with onabotulinumtoxinA: Practical guidance based on the Italian real-life post-stroke spasticity survey 73
Transcranial Direct Current Stimulation Combined with Botulinum Neurotoxin Type A Injections for Treatment of Upper Limb Intention Tremor in Multiple Sclerosis: A Case Report 72
Totale 11.378
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.008
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.008
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022703 0 0 0 67 57 54 52 52 62 61 119 179
2022/20231.644 129 79 74 35 91 147 52 87 810 18 68 54
2023/2024833 61 48 49 27 105 29 150 62 19 61 75 147
2024/20251.538 49 24 68 32 55 163 181 151 359 122 67 267
2025/20264.901 209 186 351 686 444 355 649 858 335 398 268 162
2026/20271.364 205 430 344 385 0 0 0 0 0 0 0 0
Totale 12.904